Once- versus twice-daily aspirin treatment in patients with essential thrombocytosis
Mads Lamm Larsen(Aarhus University), Erik Lerkevang Grove(Hospital South West Jutland), Peter Buur van Kooten Niekerk(Aarhus University Hospital), Søren Thorgaard Bønløkke(Aarhus University Hospital), Anne‐Mette Hvas(Aarhus University), Oliver Buchhave Pedersen(Aarhus University Hospital), Steen Dalby Kristensen(Aarhus University)
Cited by 16
Related Papers
Platelet characteristics in patients with essential thrombocytosis
|Cytometry Part B Clinical Cytometry|2018|46
Prognostic Value of Coronary CT Angiography–derived Fractional Flow Reserve on 3-year Outcomes in Patients with Stable Angina
|Radiology|2023|42
Platelet microRNA expression and association with platelet maturity and function in patients with essential thrombocythemia
|Platelets|2019|31
Rituximab-treated rheumatic patients: B cells predict seroconversion after COVID-19 boost or revaccination in initial vaccine non-responders
|Lara D. Veeken|2022|16
Recurrent Cardiovascular Events Despite Antiplatelet Therapy in a Patient with Polycythemia Vera and Accelerated Platelet Turnover
|American Journal of Case Reports|2017|12